Investors & Media

Company Overview

UNITY Biotechnology is developing therapeutics to slow, halt or reverse diseases of aging. UNITY's initial focus is on creating medicines that target cellular senescence and aging-related biology in ophthalmologic and neurologic diseases, while leveraging partnerships in growth areas with high unmet need.

Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Latest Presentation